TWO · Healthcare

LAUNXP Biomedical Co., Ltd (6876)

Biotechnology

LAUNXP Biomedical Co., Ltd (6876) is listed on TWO in the Healthcare sector. Industry: Biotechnology. As of 2026-03-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for 6876

P/E ratio

18.00

LAUNXP Biomedical Co., Ltd (6876) — FAQ

What is 6876's P/E ratio?

The price-to-earnings (P/E) ratio for LAUNXP Biomedical Co., Ltd (6876) is 18.00 (data as of 2026-03-23).

Does LAUNXP Biomedical Co., Ltd pay a dividend?

Dividend yield is not available in the current snapshot for LAUNXP Biomedical Co., Ltd (6876). Check the MyAverix Finance app for the latest dividend data.

What sector is LAUNXP Biomedical Co., Ltd in?

LAUNXP Biomedical Co., Ltd (6876) is classified in the Healthcare sector (Biotechnology industry).

What exchange is 6876 listed on?

6876 is listed on TWO.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)